Systematic Microbiome Dysbiosis Is Associated with IgA Nephropathy

This study provides microbial profiles of IgAN across multiple niches and underlines the potential of these biomarkers as promising, noninvasive tools with which to differentiate IgAN patients for clinical applications. ABSTRACT IgA nephropathy (IgAN) is reportedly associated with microbial dysbiosis. However, the microbiome dysregulation of IgAN patients across multiple niches remains unclear. To gain a systematic understanding of microbial dysbiosis, we conducted large-scale 16S rRNA gene sequencing in IgAN patients and healthy volunteers across 1,732 oral, pharynx, gut, and urine samples. We observed a niche-specific increase of several opportunistic pathogens, including Bergeyella and Capnocytophaga in the oral and pharynx, whereas some beneficial commensals decreased in IgAN patients. Similar alterations were also observed in the early versus advanced stage of chronic kidney disease (CKD) progression. Moreover, Bergeyella, Capnocytophaga, and Comamonas in the oral and pharynx were positively associated with creatinine and urea, indicating renal lesions. Random forest classifiers were developed by using the microbial abundance to predict IgAN, achieving an optimal accuracy of 0.879 in the discovery phase and 0.780 in the validation phase. IMPORTANCE This study provides microbial profiles of IgAN across multiple niches and underlines the potential of these biomarkers as promising, noninvasive tools with which to differentiate IgAN patients for clinical applications.

[1]  Shiren Sun,et al.  Expansion of Escherichia-Shigella in Gut Is Associated with the Onset and Response to Immunosuppressive Therapy of IgA Nephropathy , 2022, Journal of the American Society of Nephrology : JASN.

[2]  R. Monteiro,et al.  Is There a Role for Gut Microbiome Dysbiosis in IgA Nephropathy? , 2022, Microorganisms.

[3]  C. Heeschen,et al.  Multi-kingdom microbiota analyses identify bacterial–fungal interactions and biomarkers of colorectal cancer across cohorts , 2022, Nature Microbiology.

[4]  F. Gaiani,et al.  Oral Bacterial Microbiota in Digestive Cancer Patients: A Systematic Review , 2021, Microorganisms.

[5]  J. Gommerman,et al.  The microbiome and IgA nephropathy , 2021, Seminars in Immunopathology.

[6]  J. Novak,et al.  IgA glycosylation and immune complex formation in IgAN , 2021, Seminars in Immunopathology.

[7]  F. Servant,et al.  The Gut and Blood Microbiome in IgA Nephropathy and Healthy Controls , 2021, Kidney360.

[8]  Binbin Xu,et al.  Reduced fecal short-chain fatty acids levels and the relationship with gut microbiota in IgA nephropathy , 2021, BMC Nephrology.

[9]  P. Hou,et al.  Potential Roles of Oral Microbiota in the Pathogenesis of Immunoglobin A Nephropathy , 2021, Frontiers in Cellular and Infection Microbiology.

[10]  Timothy L. Tickle,et al.  Multivariable association discovery in population-scale meta-omics studies , 2021, bioRxiv.

[11]  Hongwei Wu,et al.  Identification of a novel interplay between intestinal bacteria and metabolites in Chinese patients with IgA nephropathy via integrated microbiome and metabolome approaches , 2020, Annals of translational medicine.

[12]  Jiaxing Tan,et al.  Modifications of gut microbiota are associated with the severity of IgA nephropathy in the Chinese population. , 2020, International immunopharmacology.

[13]  J. Chun,et al.  Comparative analysis of the tonsillar microbiota in IgA nephropathy and other glomerular diseases , 2020, Scientific Reports.

[14]  Hong Zhang,et al.  Perspectives on how mucosal immune responses, infections and gut microbiome shape IgA nephropathy and future therapies , 2020, Theranostics.

[15]  Lanjuan Li,et al.  Alterations of the Human Gut Microbiome in Chronic Kidney Disease , 2020, Advanced science.

[16]  Ruixin Zhu,et al.  Identification of microbial markers across populations in early detection of colorectal cancer , 2020, Nature Communications.

[17]  L. Chang,et al.  Integrative metagenomic and metabolomic analyses reveal severity-specific signatures of gut microbiota in chronic kidney disease , 2020, Theranostics.

[18]  Jie Du,et al.  Fecal microbiota characteristics of Chinese patients with primary IgA nephropathy: a cross-sectional study , 2020, BMC Nephrology.

[19]  Shiren Sun,et al.  A Comparative Study of the Gut Microbiota Associated With Immunoglobulin a Nephropathy and Membranous Nephropathy , 2020, Frontiers in Cellular and Infection Microbiology.

[20]  Shuhei Naka,et al.  Specific strains of Streptococcus mutans, a pathogen of dental caries, in the tonsils, are associated with IgA nephropathy , 2019, Scientific Reports.

[21]  H. Pottel,et al.  New equation to estimate glomerular filtration rate in China: a reference issue. , 2019, Kidney international.

[22]  William A. Walters,et al.  Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2 , 2019, Nature Biotechnology.

[23]  J. Novak,et al.  Galactose-deficient IgA1 and the corresponding IgG autoantibodies predict IgA nephropathy progression , 2019, PloS one.

[24]  Yan Guo,et al.  Microbiome–metabolome reveals the contribution of gut–kidney axis on kidney disease , 2019, Journal of Translational Medicine.

[25]  R. Coppo.  The Gut-Renal Connection in IgA Nephropathy. , 2018, Seminars in nephrology.

[26]  Benjamin D. Kaehler,et al.  Optimizing taxonomic classification of marker-gene amplicon sequences with QIIME 2’s q2-feature-classifier plugin , 2018, Microbiome.

[27]  Benjamin D. Kaehler,et al.  Optimizing taxonomic classification of marker-gene amplicon sequences with QIIME 2’s q2-feature-classifier plugin , 2018, Microbiome.

[28]  G. Núñez,et al.  Gut microbiota: Role in pathogen colonization, immune responses, and inflammatory disease , 2017, Immunological reviews.

[29]  J. V. van Laar,et al.  Microbial Dysbiosis in Common Variable Immune Deficiencies: Evidence, Causes, and Consequences. , 2017, Trends in immunology.

[30]  Paul J. McMurdie,et al.  DADA2: High resolution sample inference from Illumina amplicon data , 2016, Nature Methods.

[31]  Duu-Jong Lee,et al.  Denitrifying sulfide removal process on high-salinity wastewaters in the presence of Halomonas sp. , 2016, Applied Microbiology and Biotechnology.

[32]  R. Coppo,et al.  IgA nephropathy and infections , 2016, Journal of Nephrology.

[33]  J. Bandari,et al.  Renal biopsy for medical renal disease: indications and contraindications. , 2016, The Canadian journal of urology.

[34]  A. Cambier,et al.  Molecular Insights into the Pathogenesis of IgA Nephropathy. , 2015, Trends in molecular medicine.

[35]  Beiwen Zheng,et al.  Alterations of the human gut microbiome in liver cirrhosis , 2014, Nature.

[36]  Qiang Feng,et al.  A metagenome-wide association study of gut microbiota in type 2 diabetes , 2012, Nature.

[37]  Jonathan Friedman,et al.  Inferring Correlation Networks from Genomic Survey Data , 2012, PLoS Comput. Biol..

[38]  Mathieu Bastian,et al.  Gephi: An Open Source Software for Exploring and Manipulating Networks , 2009, ICWSM.

[39]  Zhi-Hong Liu,et al.  Epidemiologic data of renal diseases from a single unit in China: analysis based on 13,519 renal biopsies. , 2004, Kidney international.

[40]  G. D'Amico,et al.  Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome. , 2004, Seminars in Nephrology.

[41]  T. Kurita-Ochiai,et al.  Purification of immunosuppressive factor from Capnocytophaga ochracea. , 1998, Journal of medical microbiology.

[42]  J. S. van der Hoeven,et al.  Degradation of immunoglobulin G by periodontal bacteria. , 1994, Oral microbiology and immunology.

[43]  P. Sansonetti,et al.  Shigella and Enteroinvasive Escherichia Coli. , 2018, Current topics in microbiology and immunology.

[44]  F. Gejyo,et al.  [Haemophilus parainfluenzae antigens in IgA nephropathy]. , 1998, Rinsho byori. The Japanese journal of clinical pathology.

[45]  Y. Endo,et al.  Experimental immunoglobulin A nephropathy induced by gram-negative bacteria. , 1993, Nephron.

[46]  P. Zucchelli,et al.  [IgA nephropathy]. , 1985, Medicina clinica.